期刊文献+

肺炎衣原体研究进展 被引量:2

下载PDF
导出
摘要 肺炎衣原体是1989年被正式命名的新的衣原体种,大量证据表明它与哮喘和冠状动脉粥样硬化等慢性疾病的发生和发展有密切联系;研究还表明:在大量献血者的外周血中检测到了肺炎衣原体。本文就肺炎衣原体的特性、与哮喘和冠状动脉粥样硬化等慢性疾病的关系以及是否通过输血传播肺炎衣原体综述如下。
出处 《实验与检验医学》 CAS 2008年第5期537-538,530,共3页 Experimental and Laboratory Medicine
  • 相关文献

参考文献29

  • 1Darid A.Leiby Ph.D.,赵凤锦,赵大为.肺炎衣原体:能加入输血传播病原体的目录上吗?[J].国外医学(输血及血液学分册),2003,26(5):451-452. 被引量:3
  • 2施毅,康晓明.肺炎衣原体感染—一种新的呼吸系统致病原[J].中华结核和呼吸杂志,1991,14(4):239-241. 被引量:12
  • 3[3]Theegarten D,Mogilevski G,Anhonn O,et al.The role of chlamydia in the pathogenesis of pulmonary emphysema.Electron microscopy and immunofluorescence reveal corresponding findings as in atherosclerosis[J].Virchows Arch,2000,437(2):190~193. 被引量:1
  • 4[4]Schafer H.Acute exacerbations in chronic obstructive pulmonary disease (COPD)-microbial patterns and risk factors[J].Monaldi ArchChest Dis,2000,55(5):415~419. 被引量:1
  • 5[5]Saikku P,Leinonen M,Mattila K,et al.Serological evidence of an association of a novel Chlamydia TWAR with chronic coronary beaut disease and acute niyocardial infection[J].Lancet,1988,2(18):983~986. 被引量:1
  • 6[6]Jackson L A,Campbell L A,Kno C C,et al.Isolation of chlamydia pneumoniae i' rom a carotid atherosclerotic plaque specimen[J].J Infect Dis,1997,176(1):292~295. 被引量:1
  • 7[7]Davidson M,Kuo C C,Middan gh J P d.Confirmed previous infection with chlamydia pneumoniae (TWAR)and its presence in early coronary atherosclerusis[J].Circulation,1998,98(7):628~633. 被引量:1
  • 8[8]Sessa R,Pictro M D,Santlno I,et al.Chlamydia pneumoniae infection and atheroaclerotie eorolqary disease[J].Am Heat,1999,137(6):1116~1119. 被引量:1
  • 9[9]Danesh J,Whineup P,Lewington S,et al.Chlamydia pneumoniae IgA titres and coronary heart disease:prospective study and meta-analysis[J].Eur Heart,2002,23(5):371~375. 被引量:1
  • 10[10]Hu H,Pierce GN,Zhong G.The atherogenic effects of Chlamydia are dependent on selumcholesterol and specific to Chlamydia pneumoniae[J].Clin Invest,1999,103(5):747~753. 被引量:1

二级参考文献43

  • 1冯根宝,鲁刚,朱清於,詹化文,胡兰萍,施毅.动脉粥样硬化症与肺炎衣原体感染——91例尸检结果报告[J].医学研究生学报,1999,12(2):36-39. 被引量:13
  • 2Heick A, Strier E.Chlamydia pneumonae-associated ADEM [J].Eur J Neurl, 2000,7(4):435-438. 被引量:1
  • 3Fagerberg B, Gnarpe J, Gnarpe H, et al.Chlamydia pneumoniae but not cytomeg alovirus antibodies are associated with future risk of stroke and cardiovascular disease [J].Stroke,1999,30:299-305. 被引量:1
  • 4Leinonen M, Kerttula Y, Weber T, et al.Acute phase response in Chlamydia pneumoniae pneumonia.In:Abstracts of the 5th European Congress on Clinical Microbiology and Infectious Diseases[D], September 8-11, 1991.Oslo, Norway:1991:86. 被引量:1
  • 5Gnarpe J, Sparr A, N??s J, et al.Serological analysis of specific IgA to Chlamydia pneumoniae:increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration [J].APMIS,2000,108:357- 362. 被引量:1
  • 6Ericson K, Saldeen GP, Lindquist O, et al.Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis [J].Circulation, 2000,101:2568-2571. 被引量:1
  • 7Ingalls RR, Rice PA, Qureshi N, et al.The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated [J].Infect Immun, 1995, 63:3125-3130. 被引量:1
  • 8Jes S, Lindholt, St?vring J, et al.Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms [J].Circulation, 2004,109(17):2097-2102. 被引量:1
  • 9Wang S.The microimmunofluorescence test for Chlamydia pneumoniae infection:technique and interpretation [J].J Infect Dis, 2000,181(Suppl 3):421-425. 被引量:1
  • 10Sawayama Y, Tatsukawa M, Okada K, et al.Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins[J].Atherosclerosis, 2003,171(2):281-285. 被引量:1

共引文献33

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部